Search Results 281-290 of 2430 for ⚕[광고텔레:TOOPPC] 선불유심홍보 파워볼솔루션홍보 구글출장광고 백링크 신용카드현금화광고 법인통장구매⚕

1. A Phase 1/2 Study to Evaluate MEDI4736 - Clinical Trials

   This is a multicenter, open-label, first-time-in-human study with a standard 3+3 dose-escalation phase in subjects with advanced solid tumors followed by an ...

2. A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders - Mayo Clinic

   About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.

3. Establishment of Disease Ranges of Selected Markers and Ratios for the Detection of OTC Deficiency and CPS Deficiency using Newborn Blood Spots - Mayo Clinic

   About this study. The purpose of this study is to obtain and analyze existing newborn screening data from previously identified patients with a confirmed ...

4. Genomic Analysis of Glioma Tissue Samples - Mayo Clinic

   The purpose of this study is to use stored glioma specimens stored by the Tissue Registry under the oversight of the Neuro-Oncology program. Participating Mayo ...

5. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing ...

6. Oxaliplatin, Leucovorin Calcium, and Fluorouracil with or without Celecoxib in Treating Patients with Stage III Colon Cancer Previously Treated with Surgery - Mayo Clinic

   Celecoxib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether giving oxaliplatin, leucovorin ...

7. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

   This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...

8. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability and drug/body interactions of C2N-8E12 in patients with progressive supranuclear palsy.

9. Alumni - Gastrointestinal Mechanotransduction: Arthur Beyder - Mayo Clinic Research

   Alumni. Anthony (A.J.) Treichel, Graduate Research Employment Program (GREP), 2017-2019; Gulcan Yildiz, visiting research fellow, 2017-2018; Alecia L. Alto, ...

10. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    Lenalidomide may stimulate the immune system in different ways and stop cancer cells from growing. It is not yet known whether rituximab and combination ...